| | fVAS | | FSS | | SF-36vsa |
|---|
B | p-value | | B | p-value | | B | p-value |
|---|
HADS-D | 2.26 | 0.01 | HADS-D | 0.23 | < 0.001 | HADS-D | 2.89 | < 0.001 |
SF-36bp scorea | 0.48 | < 0.001 | SF-36bp scorea | 0.03 | < 0.001 | SF-36bp scorea | 0.38 | < 0.001 |
HSP90α, ng/mL | 0.72 | 0.01 | HMGB1, ng/mL | 0.56 | 0.047 | IL-1RA, pg/mL | 0.03 | 0.002 |
Model summary | R2 = 0.47, p < 0.001 | Model summary | R2 = 0.56, p < 0.001 | Model summary | R2 = 0.58, p < 0.001 |
- #Forward and backward selection yielded identical results. aSF-36vs- and SF-36bp scores are reported as inverted values, with high numbers indicating low vitality/high bodily pain and low numbers indicating high vitality/low bodily pain. Data are from 56 patients with Crohn’s disease
- fVAS fatigue visual analog scale, FSS Fatigue Severity Scale, HADS-D depression subscale of the Hospital Anxiety and Depression Scale, HMGB1 high mobility group box 1, HSP heat shock protein, IL-1RA interleukin-1 receptor antagonist, SF-36 Medical Outcomes Study Short-form Health Survey, SF-36bp the bodily pain subscale of SF-36, SF-36vs the vitality subscale of SF-36
